Gene · 129607
NIH grants1,236
NIH grants whose papers are about the gene, through NIH's grant-paper links.
301 to 320 of 1,236
Download this page as JSON| Grant | Title | CMPK2 papers | Newest fiscal year |
|---|---|---|---|
| R01GM138385 | Annotation of cell types in human colon tissue using Boolean analysis | 1 | 2023 |
| R01HD091327 | Acetylcholine Receptors in Cell Migrationis | 1 | 2023 |
| R01HL117836 | Functional Studies of Novel Genes Mutated in Primary Ciliary Dyskinesia II: Genotype to Phenotype | 1 | 2023 |
| R01HL142629 | Mechanisms of myelopoiesis after myocardial infarction | 1 | 2023 |
| R01HL153312 | Lung transplant injury drives chronic lung allograft dysfunction via recruitment ofmonocyte-derived alveolar macrophages | 1 | 2023 |
| R03AG073985 | Epigenetic markers, functional status, and exercise in older adults with myeloid neoplasms | 1 | 2023 |
| R03HL161595 | Computational analysis of whole genome sequence data for discovering novel risk genes of structural birth defects | 1 | 2023 |
| R21AR079089 | Genetic risk of hidradenitis suppurativa in African Americans | 1 | 2023 |
| R33HD105618 | Discovery and clinical validation of host biomarkers of disease severity and multi-system inflammatory syndrome in children (MIS-C) with Covid-19 | 1 | 2023 |
| R35HL135799 | Non-coding RNA regulation of cholesterol homeostasis and atherosclerosis | 1 | 2023 |
| T32GM007750 | Drug Action, Metabolism and Kinetics Training Grant | 1 | 2023 |
| T32GM007752 | Graduate Training in Cellular and Molecular Pharmacology | 1 | 2023 |
| T32GM008042 | UCLA-Caltech Medical Scientist Training Program | 1 | 2023 |
| U01CA272612 | Translating novel cancer targets and mechanisms from the CTD^2 Network using molecular glues | 1 | 2023 |
| U19AI142784 | Autophagy Modulators as Novel Broad-Spectrum Anti-Infective Agents | 1 | 2023 |
| U19AI142785 | Advancement of Vaccines and Treatments for Ebola and Marburg Virus Infections | 1 | 2023 |
| U54HL096458 | Genetic Disorders of Mucociliary Clearance | 1 | 2023 |
| U54NS065705 | Brain Vascular Malformation Consortium: Predictor's of Clinical Course | 1 | 2023 |
| U54NS078059 | The North American Mitochondrial Disease Consortium (NAMDC) | 1 | 2023 |
| UL1TR001422 | Northwestern University Clinical and Translational Science Institute (NUCATS) | 1 | 2023 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/129607/grants?page=16